Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Novartis
Colorcon
Medtronic
Cerilliant
Dow
Cipla
Julphar
AstraZeneca
Farmers Insurance

Generated: February 23, 2018

DrugPatentWatch Database Preview

Dr Reddys La Company Profile

« Back to Dashboard

What is the competitive landscape for DR REDDYS LA, and when can generic versions of DR REDDYS LA drugs launch?

DR REDDYS LA has one hundred and eighty-one approved drugs.

There are five US patents protecting DR REDDYS LA drugs on DR REDDYS LA drugs in the past three years. There are eleven tentative approvals on DR REDDYS LA drugs.

There are ninety-three patent family members on DR REDDYS LA drugs in forty-eight countries and two hundred and forty supplementary protection certificates in thirteen countries.

Summary for Dr Reddys La
International Patents:93
US Patents:5
Tradenames:141
Ingredients:125
NDAs:181

Drugs and US Patents for Dr Reddys La

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Inc AMOXIL amoxicillin FOR SUSPENSION;ORAL 050760-002 Apr 15, 1999 DISCN Yes No ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 076183-003 Dec 26, 2006 AB RX No No ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 076534-002 Oct 24, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Sa EZETIMIBE AND SIMVASTATIN ezetimibe; simvastatin TABLET;ORAL 200909-004 Apr 26, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 202017-001 Sep 12, 2013 AP RX No No ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd LAMOTRIGINE lamotrigine TABLET, EXTENDED RELEASE;ORAL 202383-004 Jun 19, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 076502-007 Apr 12, 2011 OTC No No ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Inc AUGMENTIN '500' amoxicillin; clavulanate potassium TABLET;ORAL 050564-002 Aug 6, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM amlodipine besylate; atorvastatin calcium TABLET;ORAL 203874-009 Mar 7, 2014 AB RX No No ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET;ORAL 065436-001 Dec 26, 2007 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Dr Reddys La

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 4,597,961 ➤ Sign Up
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 4,597,961 ➤ Sign Up
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 5,834,011 ➤ Sign Up
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,016,652 ➤ Sign Up
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 4,597,961 ➤ Sign Up
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 5,016,652 ➤ Sign Up
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,834,011 ➤ Sign Up
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 5,016,652 ➤ Sign Up
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 5,834,011 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for DR REDDYS LA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 6/3/2015
➤ Subscribe Extended-release Tablets 1000 mg/62.5 mg ➤ Subscribe 1/21/2009

Non-Orange Book US Patents for Dr Reddys La

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,294,199 Method of treating a bacterial infection comprising administering amoxycillin ➤ Sign Up
6,660,299 Modified release pharmaceutical formulation comprising amoxycillin ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Dr Reddys La Drugs

Country Document Number Estimated Expiration
Denmark 1044680 ➤ Sign Up
Ukraine 71609 ➤ Sign Up
Australia 5702000 ➤ Sign Up
Turkey 200102963 ➤ Sign Up
Malaysia 119953 ➤ Sign Up
Poland 197448 ➤ Sign Up
Germany 60003255 ➤ Sign Up
Slovenia 20304 ➤ Sign Up
Slovakia 285140 ➤ Sign Up
United Kingdom 2365337 ➤ Sign Up
Country Document Number Estimated Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Dr Reddys La Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00028 Netherlands ➤ Sign Up PRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929
2015000006 Germany ➤ Sign Up PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718
00055 Netherlands ➤ Sign Up PRODUCT NAME: SIROLIMUS, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT; NATL. REGISTRATION NO/DATE: EU/1/01/171/001 - EU/1/01/171/005 20010313; FIRST REGISTRATION: CH CH/55243 20000926
2011005,C0984957 Lithuania ➤ Sign Up PRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126
02C/035 Belgium ➤ Sign Up PRODUCT NAME: MEMANTINE; REGISTRATION NO/DATE: EU/1/02/219/001 20020517
C/GB01/036 United Kingdom ➤ Sign Up PRODUCT NAME: SIROLIMUS; REGISTERED: CH IKS 55243 20000926; UK EU/1/01/171/001-005 20010313
2014026 Lithuania ➤ Sign Up PRODUCT NAME: DAPAGLIFOZINUM + METFORMINUM; REGISTRATION NO/DATE: EU/1/13/900 20140116
C/GB08/025 United Kingdom ➤ Sign Up PRODUCT NAME: TEMSIROLIMUS AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/07/424/001 20071119
315 Luxembourg ➤ Sign Up PRODUCT NAME: COMBINAISON COMPRENANT ALISKIREN,OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE,ET AMLODIPINE,OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE
C/GB98/041 United Kingdom ➤ Sign Up PRODUCT NAME: RIVASTIGMINE, AS FREE BASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: CH 5427501 19970731; CH 5427502 19970731; CH 5427503 19970731; CH 5427504 19970731; CH 5427505 19970731; CH 5427506 19970731; UK EU/1/98/066/001 19980512; UK EU/1/98/066/002 19980512; UK EU/1/98/066/003 19980512; UK EU/1/98/066/004 19980512; UK EU/1/98/066/005 19980512; UK EU/1/98/066/006 19980512; UK EU/1/98/092/023 19980512; UK EU/1/98/092/024 19980512; UK EU/1/98/092/025 19980512; UK EU/1/98/092/026 19980512; UK EU/1/98/066/025 19980512; UK EU/1/98/066/026 19980512; UK EU/1/98/092/019 19980512; UK EU/1/98/092/020 19980512; UK EU/1/98/092/021 19980512; UK EU/1/98/092/022 19980512; UK EU/1/98/0
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Cantor Fitzgerald
Merck
McKesson
Accenture
Healthtrust
Fuji
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot